As a consequence of advances in care, life expectancy has significantly increased for many people with HIV. In Australia, the focus of care has shifted from acute illness and palliative care to chronic disease management. Many people with HIV receive much of their medical care from general practitioners. It is therefore important to know which problems can be managed in general practice and when these patients should be referred.
Introduction
In 2009 it was estimated that 20 171 people were living with HIV in Australia. 1 As overall HIV infection numbers increase and uptake of more effective and less toxic antiretroviral therapy becomes more widespread, this population is going to increase and live longer. As a consequence, it is likely that more general practitioners will become involved in the care of people living with HIV. An understanding of the standard care, general management and medication-related issues is important.
To become a community prescriber of antiretroviral therapy for HIV, general practitioners need to complete an accredited training course. Details of training courses are on the Australasian Society of HIV Medicine website (www.ashm.org.au).
Standard care of a person with HIV
The aim of antiretroviral therapy is to achieve long-term control of HIV replication, enabling recovery and improved functioning of the immune system. The goal is to suppress the plasma viral load to below 40 copies/mL, which is the lowest point of detection in most routine assays.
Initiating therapy
Current guidelines 2 advise starting treatment if there is an AIDS-defining illness or a CD4 count below 350 cells/microlitre.
There is some research (based on cumulative observational cohort data) to support earlier treatment for people with CD4 counts above 350 cells/microlitre, 3 but current opinion is divided on this. 4 In certain circumstances, treatment is initiated regardless of the CD4 count 5 
Regular monitoring

Mental health
Mental health problems, particularly depression and anxiety disorders, are common among people living with HIV.
HIV-positive men have high rates of major depression -a study of gay men in urban general practice revealed that 32% of HIV can cause dementia and there is evidence that cognitive impairment develops earlier among people with HIV. 9 It impairs treatment compliance and adds to morbidity and mortality.
General practitioners are involved in the management of mental health problems, including pharmacotherapy, developing
Medicare-funded mental health treatment plans with their patients and facilitating referral for psychological therapy.
Prophylaxis
Prophylaxis against Pneumocystis jirovecii pneumonia, usually trimethoprim with sulfamethoxazole, is recommended for patients with CD4 cell counts less than 200 cells/microlitre.
Trimethoprim with sulfamethoxazole can also be used as prophylaxis against toxoplasmosis.
Patients with advanced immunodeficiency (CD4 cell count <50 cells/microlitre) should be considered for prophylaxis against Mycobacterium avium complex. Azithromycin is usually the best tolerated drug with fewest interactions.
Vaccinations
It is important for general practitioners to be familiar with recommendations around vaccinations ( 
Chronic disease management
General practitioners are ideally placed to manage many of the complex issues facing the individual with HIV infection.
A number of these problems are in fact familiar to general practitioners looking after people with any chronic condition. 
Osteopenia and osteoporosis
These conditions can be associated with androgen deficiency, low body weight and the use of tenofovir. As the cohort of people living with HIV ages, these conditions will become more prevalent. 13 Consider alcohol intake as well. Atazanavir commonly causes hyperbilirubinaemia for which no action is required.
Gastrointestinal intolerance
The protease inhibitors lopinavir/ritonavir, fosamprenavir and ritonavir are associated with diarrhoea. Psyllium, loperamide or diphenoxylate/atropine can be trialled to relieve symptoms. 
Lipodystrophy
Effects to look out for that may be related to medications
Haematology
Zidovudine and other antiretrovirals are associated with a benign increase in mean cell volume. This is not harmful, but other causes need to be considered and excluded. Zidovudine can also cause life-threatening haemolytic anaemia and bone marrow suppression.
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HIV infection causes thrombocytopenia which can respond to antiretroviral therapy. There are member organisations in every state and territory.
Drug interactions
Contact the national office for up-to-date details.
